Litcius/Paper detail

Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer’s disease

Pourya Naderi Yeganeh, Sang Su Kwak, Mehdi Jorfi, Katjuša Koler, Thejesh Kalatturu, Djuna von Maydell, Zhiqing Liu, Kevin Guo, Younjung Choi, Joseph Park, Nelson Abarca, Grisilda Bakiasi, Murat Çetinbaş, Ruslan I. Sadreyev, Ana Griciuc, Luisa Quinti, Se Hoon Choi, Weiming Xia, Rudolph E. Tanzi, Winston Hide, Doo Yeon Kim

2024Neuron18 citationsDOIOpen Access PDF

Topics & Concepts

NeuroscienceMAPK/ERK pathwayDiseasePsychologyFunctional connectivityAlzheimer's diseaseBiologySignal transductionMedicineCell biologyPathologyAlzheimer's disease research and treatmentsComputational Drug Discovery MethodsCholinesterase and Neurodegenerative Diseases
Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer’s disease | Litcius